Literature DB >> 17980881

Strains of Sarcocystis neurona exhibit differences in their surface antigens, including the absence of the major surface antigen SnSAG1.

Daniel K Howe1, Rajshekhar Y Gaji, Antoinette E Marsh, Bhagyashree A Patil, William J Saville, David S Lindsay, J P Dubey, David E Granstrom.   

Abstract

A gene family of surface antigens is expressed by merozoites of Sarcocystis neurona, the primary cause of equine protozoal myeloencephalitis (EPM). These surface proteins, designated SnSAGs, are immunodominant and therefore excellent candidates for development of EPM diagnostics or vaccines. Prior work had identified an EPM isolate lacking the major surface antigen SnSAG1, thus suggesting there may be some diversity in the SnSAGs expressed by different S. neurona isolates. Therefore, a bioinformatic, molecular and immunological study was conducted to assess conservation of the SnSAGs. Examination of an expressed sequence tag (EST) database revealed several notable SnSAG polymorphisms. In particular, the EST information implied that the EPM strain SN4 lacked the major surface antigen SnSAG1. The absence of this surface antigen from the SN4 strain was confirmed by both Western blot and Southern blot. To evaluate SnSAG polymorphisms in the S. neurona population, 14 strains were examined by Western blots using monospecific polyclonal antibodies against the four described SnSAGs. The results of these analyses demonstrated that SnSAG2, SnSAG3, and SnSAG4 are present in all 14 S. neurona strains tested, although some variance in SnSAG4 was observed. Importantly, SnSAG1 was not detected in seven of the strains, which included isolates from four cases of EPM and a case of fatal meningoencephalitis in a sea otter. Genetic analyses by PCR using gene-specific primers confirmed the absence of the SnSAG1 locus in six of these seven strains. Collectively, the data indicated that there is heterogeneity in the surface antigen composition of different S. neurona isolates, which is an important consideration for development of serological tests and prospective vaccines for EPM. Furthermore, the diversity reported herein likely extends to other phenotypes, such as strain virulence, and may have implications for the phylogeny of the various Sarcocystis spp. that undergo sexual stages of their life cycle in opossums.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980881     DOI: 10.1016/j.ijpara.2007.09.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  9 in total

1.  A novel Sarcocystis neurona genotype XIII is associated with severe encephalitis in an unexpectedly broad range of marine mammals from the northeastern Pacific Ocean.

Authors:  Lorraine Barbosa; Christine K Johnson; Dyanna M Lambourn; Amanda K Gibson; Katherine H Haman; Jessica L Huggins; Amy R Sweeny; Natarajan Sundar; Stephen A Raverty; Michael E Grigg
Journal:  Int J Parasitol       Date:  2015-05-18       Impact factor: 3.981

Review 2.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

3.  Molecular characterization of Sarcocystis neurona strains from opossums (Didelphis virginiana) and intermediate hosts from Central California.

Authors:  Daniel Rejmanek; Melissa A Miller; Michael E Grigg; Paul R Crosbie; Patricia A Conrad
Journal:  Vet Parasitol       Date:  2010-02-11       Impact factor: 2.738

4.  Parasitemia due to Sarcocystis neurona-like infection in a clinically ill domestic cat.

Authors:  Nina C Zitzer; Antoinette E Marsh; Mary Jo Burkhard; M Judith Radin; Maxey L Wellman; Maria Jugan; Valerie Parker
Journal:  Vet Clin Pathol       Date:  2017-09-11       Impact factor: 1.180

5.  Limited genetic diversity among Sarcocystis neurona strains infecting southern sea otters precludes distinction between marine and terrestrial isolates.

Authors:  J M Wendte; M A Miller; A K Nandra; S M Peat; P R Crosbie; P A Conrad; M E Grigg
Journal:  Vet Parasitol       Date:  2009-12-22       Impact factor: 2.738

6.  Evidence that antibodies against recombinant SnSAG1 of Sarcocystis neurona merozoites are involved in infection and immunity in equine protozoal myeloencephalitis.

Authors:  Siobhan Ellison; Sharon Witonsky
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

7.  Integrated bioinformatic and targeted deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator of Toxoplasma virulence.

Authors:  James D Wasmuth; Viviana Pszenny; Simon Haile; Emily M Jansen; Alexandra T Gast; Alan Sher; Jon P Boyle; Martin J Boulanger; John Parkinson; Michael E Grigg
Journal:  MBio       Date:  2012-11-13       Impact factor: 7.867

8.  Systems-based analysis of the Sarcocystis neurona genome identifies pathways that contribute to a heteroxenous life cycle.

Authors:  Tomasz Blazejewski; Nirvana Nursimulu; Viviana Pszenny; Sriveny Dangoudoubiyam; Sivaranjani Namasivayam; Melissa A Chiasson; Kyle Chessman; Michelle Tonkin; Lakshmipuram S Swapna; Stacy S Hung; Joshua Bridgers; Stacy M Ricklefs; Martin J Boulanger; Jitender P Dubey; Stephen F Porcella; Jessica C Kissinger; Daniel K Howe; Michael E Grigg; John Parkinson
Journal:  mBio       Date:  2015-02-10       Impact factor: 7.867

Review 9.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.